The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Personalized medicine is transforming cancer treatment by tailoring therapies to the genomic profile of each tumor. Next-generation sequencing (NGS) is key to this approach, but its complexity and ...

Next-generation sequencing (NGS) has transformed biomedical research, offering unprecedented insights into diseases ranging from cancer to rare genetic disorders. The rapid sequencing of tumors and ...

Consultant, Medical Oncology, Tata Memorial Hospital, Mumbai, India; Chair Professor (CoE), Cancer Research in Genetics, Maharashtra University of Health Sciences (MUHS), Maharashtra, India ...

Request To Download Free Sample of This Strategic Report@ Introduction: The Vietnam PCR & NGS Based Diagnostic Testing Market Report offers a comprehensive analysis of the landscape and trends ...

There is an expanding list of therapeutically relevant biomarkers for non-small cell lung cancer (NSCLC), and molecular profiling at diagnosis is paramount. Tissue attrition in scaling traditional ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 ...